Nimesulide
Sandbox drug2
Sandbox drug2®
Black Box Warning
Adult Indications and Dosage
Pediatric Indications and Dosage
Contraindications
Warnings
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration and Monitoring
IV Compatibility
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Drug Names
Drug Shortage Status
Price
For patient information regarding , click [[{{{genericName}}} (patient information)|here]].
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Black Box Warning
ConditionName:
See full prescribing information for complete boxed warning.
ConditionName:
Content
Overview
Sandbox drug2 is a {{{drugClass}}} that is FDA approved for the treatment of {{{indication}}}. There is a Black Box Warning for this drug as shown here. Common adverse reactions include .
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)Condition1 Dosing Information
Dosage
Condition2 Dosing Information
Dosage
Condition3 Dosing Information
Dosage
Condition4 Dosing Information
Dosage
Off-Label Use and Dosage (Adult)Guideline-Supported UseCondition1 Developed by:
Class of Recommendation:
Strength of Evidence:
Dosing Information
Dosage
Condition2
There is limited information regarding Off-Label Guideline-Supported Use of Sandbox drug2 in adult patients.
Non–Guideline-Supported Use
Condition1 Dosing Information
Dosage
Condition2
There is limited information regarding Off-Label Non–Guideline-Supported Use of Sandbox drug2 in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)Condition1 Dosing Information
Dosage
Condition2
There is limited information regarding FDA-Labeled Use of Sandbox drug2 in pediatric patients.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported UseCondition1 Developed by:
Class of Recommendation:
Strength of Evidence:
Dosing Information
Dosage
Condition2
There is limited information regarding Off-Label Guideline-Supported Use of Sandbox drug2 in pediatric patients.
Non–Guideline-Supported Use
Condition1 Dosing Information
Dosage
Condition2
There is limited information regarding Off-Label Non–Guideline-Supported Use of Sandbox drug2 in pediatric patients.
Contraindications
Condition1
Warnings
ConditionName:
See full prescribing information for complete boxed warning.
ConditionName:
Content
Description
Precautions Description
Adverse ReactionsClinical Trials Experience
There is limited information regarding Clinical Trial Experience of Sandbox drug2 in the drug label.
Body as a Whole
CardiovascularDigestiveEndocrineHematologic and LymphaticMetabolic and NutritionalMusculoskeletalNeurologicRespiratorySkin and Hypersensitivy ReactionsSpecial SensesUrogenitalMiscellaneousPostmarketing Experience
There is limited information regarding Postmarketing Experience of Sandbox drug2 in the drug label.
Body as a Whole
CardiovascularDigestiveEndocrineHematologic and LymphaticMetabolic and NutritionalMusculoskeletalNeurologicRespiratorySkin and Hypersensitivy ReactionsSpecial SensesUrogenitalMiscellaneousDrug Interactions Drug
Description
Use in Specific PopulationsPregnancy
Pregnancy Category (FDA):
Pregnancy Category
Pregnancy Category (AUS):
Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Sandbox drug2 in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Sandbox drug2 during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Sandbox drug2 with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Sandbox drug2 with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Sandbox drug2 with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Sandbox drug2 with respect to specific gender populations.
Race
There is no FDA guidance on the use of Sandbox drug2 with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Sandbox drug2 in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Sandbox drug2 in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Sandbox drug2 in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Sandbox drug2 in patients who are immunocompromised.
Administration and Monitoring
Administration Oral
Intravenous
Monitoring
There is limited information regarding Monitoring of Sandbox drug2 in the drug label.
Description
IV Compatibility
There is limited information regarding IV Compatibility of Sandbox drug2 in the drug label.
Overdosage
Acute OverdoseSigns and Symptoms Description
Management Description
Chronic Overdose
There is limited information regarding Chronic Overdose of Sandbox drug2 in the drug label.
Pharmacology
Mechanism of Action
Structure
File:Sandbox drug201.png
This image is provided by the National Library of Medicine.
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Sandbox drug2 in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Sandbox drug2 in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Sandbox drug2 in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Sandbox drug2 in the drug label.
How Supplied
Images
Drug Images
Drug Name: Ingredient(s): Imprint: Dosage: {{{dosageValue}}} {{{dosageUnit}}} Color(s): Shape: Size (mm): Score: NDC:
Drug Label Author:
This pill image is provided by the National Library of Medicine's PillBox.
Package and Label Display Panel
File:Sandbox drug211.png
This image of the FDA label is provided by the National Library of Medicine.
Patient Counseling Information
There is limited information regarding Patient Counseling Information of Sandbox drug2 in the drug label.
Precautions with Alcohol
Alcohol-Sandbox drug2 interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names ®[1]
Look-Alike Drug Names A® — B®[2]
Drug Shortage StatusPrice
References
The contents of this FDA label are provided by the National Library of Medicine.
Jump up↑ You must specify title = and url = when using Empty citation (help)..